Page last updated: 2024-11-03

practolol and Crush Syndrome

practolol has been researched along with Crush Syndrome in 1 studies

Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.

Crush Syndrome: Severe systemic manifestation of trauma and ischemia involving soft tissues, principally skeletal muscle, due to prolonged severe crushing. It leads to increased permeability of the cell membrane and to the release of potassium, enzymes, and myoglobin from within cells. Ischemic renal dysfunction secondary to hypotension and diminished renal perfusion results in acute tubular necrosis and uremia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ellis, H1

Reviews

1 review available for practolol and Crush Syndrome

ArticleYear
Review of general surgery 1977.
    Postgraduate medical journal, 1978, Volume: 54, Issue:632

    Topics: Anti-Bacterial Agents; Cholangiography; Contraceptives, Oral; Crohn Disease; Crush Syndrome; Duodena

1978